Find Therapeutics Announces First Subject Dosed in Phase 1 Clinical Study of FTX-101

20232024

Oct 21

Written By Guest User

Guest User

Epitopea Closes USD $31 million Pre-Series A Financing

AstraZeneca Closes Acquisition of Amolyt Pharma